US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist
  • 1.0300
  • +0.0600+6.19%
Close Apr 26 16:00 ET
  • 1.0600
  • +0.0300+2.91%
Post 18:41 ET
35.80MMarket Cap-804P/E (TTM)

Unicycive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-29.02%675K
0
0
0
675K
951K
0
951K
0
0
Operating revenue
-29.02%675K
--0
--0
--0
--675K
--951K
--0
--951K
--0
--0
Cost of revenue
Gross profit
Operating expense
12.87%21.45M
18.55%6.31M
-8.72%5.94M
18.87%4.32M
37.89%4.88M
111.69%19M
93.50%5.33M
37.96%6.51M
366.75%3.64M
383.86%3.54M
Selling and administrative expenses
30.15%8.55M
40.07%2.08M
50.76%2.57M
15.71%2.06M
15.15%1.85M
126.68%6.57M
6.76%1.49M
81.26%1.7M
520.98%1.78M
470.82%1.6M
-General and administrative expense
30.15%8.55M
40.07%2.08M
50.76%2.57M
15.71%2.06M
15.15%1.85M
126.68%6.57M
6.76%1.49M
81.26%1.7M
520.98%1.78M
470.82%1.6M
Research and development costs
3.75%12.9M
10.23%4.23M
-29.79%3.37M
21.88%2.27M
56.75%3.03M
104.54%12.44M
182.15%3.84M
27.20%4.8M
277.28%1.86M
329.56%1.93M
Operating profit
-15.08%-20.77M
-18.55%-6.31M
-6.91%-5.94M
-18.87%-4.32M
-18.80%-4.2M
-101.09%-18.05M
-93.50%-5.33M
-17.79%-5.55M
-366.75%-3.64M
-383.86%-3.54M
Net non-operating interest income expense
8,983.33%533K
4,133.33%121K
7,066.67%209K
202K
2K
99.04%-6K
-3K
94.55%-3K
0
0
Non-operating interest income
--615K
--140K
--227K
--234K
--14K
--0
--0
--0
--0
--0
Non-operating interest expense
1,266.67%82K
533.33%19K
500.00%18K
--32K
--12K
-99.04%6K
--3K
-94.55%3K
--0
--0
Other net income (expense)
-10.3M
-1.61M
1.4M
282K
-10.38M
Gain on sale of security
---10.3M
---1.61M
--1.4M
--282K
---10.38M
----
----
----
----
----
Income before tax
-69.14%-30.54M
-46.36%-7.8M
22.03%-4.33M
-5.56%-3.84M
-312.07%-14.58M
-80.27%-18.06M
-93.60%-5.33M
-6.84%-5.56M
-230.55%-3.64M
-266.91%-3.54M
Income tax
Net income
-69.14%-30.54M
-46.36%-7.8M
22.03%-4.33M
-5.56%-3.84M
-312.07%-14.58M
-80.27%-18.06M
-93.60%-5.33M
-6.84%-5.56M
-230.55%-3.64M
-266.91%-3.54M
Net income continuous Operations
-69.14%-30.54M
-46.36%-7.8M
22.03%-4.33M
-5.56%-3.84M
-312.07%-14.58M
-80.27%-18.06M
-93.60%-5.33M
-6.84%-5.56M
-230.55%-3.64M
-266.91%-3.54M
Minority interest income
Net income attributable to the parent company
-69.14%-30.54M
-46.36%-7.8M
22.03%-4.33M
-5.56%-3.84M
-312.07%-14.58M
-80.27%-18.06M
-93.60%-5.33M
-6.84%-5.56M
-230.55%-3.64M
-266.91%-3.54M
Preferred stock dividends
867K
0
72K
603K
192K
Other preferred stock dividends
Net income attributable to common stockholders
-73.95%-31.41M
-46.36%-7.8M
20.73%-4.41M
-22.14%-4.44M
-317.50%-14.77M
-80.27%-18.06M
-93.60%-5.33M
-6.84%-5.56M
-230.55%-3.64M
-266.91%-3.54M
Basic earnings per share
-6.67%-1.28
54.29%-0.16
64.86%-0.13
-20.83%-0.29
-304.17%-0.97
-39.53%-1.2
-105.88%-0.35
0.00%-0.37
-205.03%-0.24
-118.18%-0.24
Diluted earnings per share
-6.67%-1.28
54.29%-0.16
64.86%-0.13
-20.83%-0.29
-304.17%-0.97
-39.53%-1.2
-105.88%-0.35
0.00%-0.37
-205.03%-0.24
-118.18%-0.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -29.02%675K000675K951K0951K00
Operating revenue -29.02%675K--0--0--0--675K--951K--0--951K--0--0
Cost of revenue
Gross profit
Operating expense 12.87%21.45M18.55%6.31M-8.72%5.94M18.87%4.32M37.89%4.88M111.69%19M93.50%5.33M37.96%6.51M366.75%3.64M383.86%3.54M
Selling and administrative expenses 30.15%8.55M40.07%2.08M50.76%2.57M15.71%2.06M15.15%1.85M126.68%6.57M6.76%1.49M81.26%1.7M520.98%1.78M470.82%1.6M
-General and administrative expense 30.15%8.55M40.07%2.08M50.76%2.57M15.71%2.06M15.15%1.85M126.68%6.57M6.76%1.49M81.26%1.7M520.98%1.78M470.82%1.6M
Research and development costs 3.75%12.9M10.23%4.23M-29.79%3.37M21.88%2.27M56.75%3.03M104.54%12.44M182.15%3.84M27.20%4.8M277.28%1.86M329.56%1.93M
Operating profit -15.08%-20.77M-18.55%-6.31M-6.91%-5.94M-18.87%-4.32M-18.80%-4.2M-101.09%-18.05M-93.50%-5.33M-17.79%-5.55M-366.75%-3.64M-383.86%-3.54M
Net non-operating interest income expense 8,983.33%533K4,133.33%121K7,066.67%209K202K2K99.04%-6K-3K94.55%-3K00
Non-operating interest income --615K--140K--227K--234K--14K--0--0--0--0--0
Non-operating interest expense 1,266.67%82K533.33%19K500.00%18K--32K--12K-99.04%6K--3K-94.55%3K--0--0
Other net income (expense) -10.3M-1.61M1.4M282K-10.38M
Gain on sale of security ---10.3M---1.61M--1.4M--282K---10.38M--------------------
Income before tax -69.14%-30.54M-46.36%-7.8M22.03%-4.33M-5.56%-3.84M-312.07%-14.58M-80.27%-18.06M-93.60%-5.33M-6.84%-5.56M-230.55%-3.64M-266.91%-3.54M
Income tax
Net income -69.14%-30.54M-46.36%-7.8M22.03%-4.33M-5.56%-3.84M-312.07%-14.58M-80.27%-18.06M-93.60%-5.33M-6.84%-5.56M-230.55%-3.64M-266.91%-3.54M
Net income continuous Operations -69.14%-30.54M-46.36%-7.8M22.03%-4.33M-5.56%-3.84M-312.07%-14.58M-80.27%-18.06M-93.60%-5.33M-6.84%-5.56M-230.55%-3.64M-266.91%-3.54M
Minority interest income
Net income attributable to the parent company -69.14%-30.54M-46.36%-7.8M22.03%-4.33M-5.56%-3.84M-312.07%-14.58M-80.27%-18.06M-93.60%-5.33M-6.84%-5.56M-230.55%-3.64M-266.91%-3.54M
Preferred stock dividends 867K072K603K192K
Other preferred stock dividends
Net income attributable to common stockholders -73.95%-31.41M-46.36%-7.8M20.73%-4.41M-22.14%-4.44M-317.50%-14.77M-80.27%-18.06M-93.60%-5.33M-6.84%-5.56M-230.55%-3.64M-266.91%-3.54M
Basic earnings per share -6.67%-1.2854.29%-0.1664.86%-0.13-20.83%-0.29-304.17%-0.97-39.53%-1.2-105.88%-0.350.00%-0.37-205.03%-0.24-118.18%-0.24
Diluted earnings per share -6.67%-1.2854.29%-0.1664.86%-0.13-20.83%-0.29-304.17%-0.97-39.53%-1.2-105.88%-0.350.00%-0.37-205.03%-0.24-118.18%-0.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg